Belongs to

• Solid Tumor Oncology Division

Types of Work

["2020"]

[[["Journal Articles",306],["Meeting Abstracts",273],["Reviews",9],["Book Sections",5],["Guidelines",3],["Editorials",2],["Books Whole",1],["Miscellaneous",1],["Research Letters",1]]]

[601]

Popular keywords

• adult
• aged
• article
• clinical article
• controlled study
• female
• human
• major clinical study
• male
• priority journal

Recent Works

1. Safety and preliminary efficacy of vimseltinib in tenosynovial giant cell tumor (TGCT)

   Meeting Abstract

   Gelderblom, H.; Abdul Razak, A. R.; Sánchez-Gastaldo, A.; Rutkowski, P.; Wilky, B.; Wagner, A.; van de Sande, M.; Michenzie, M.; Vallee, M.; Sharma, M.; more...
   Annals of Oncology (2021)

   Fulltext@MSK | Save
2. Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study

   Meeting Abstract

   von Mehren, M.; Heinrich, C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; more...
   Annals of Oncology (2021)

   Fulltext@MSK | Save
3. A phase Ia/Ib, dose-escalation/expansion study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma

   Meeting Abstract

   Gounder, M.; Patel, M. R.; Yamamoto, N.; Bauer, T. M.; Laurie, S.; Perez-Pitarch, A.; Geng, J.; Cheng, J.; Lahmar, M.; Lorusso, P.
   Annals of Oncology (2021)

   Fulltext@MSK | Save